Moberg Derma has signed a distribution agreement with Menarini for Emtrix, in Italy, to treat discolored and damaged nails caused by nail fungus or nail psoriasis.
Subscribe to our email newsletter
Under the agreement Menarini’s OTC Division is granted exclusive rights to market and sell Emtrix under the trademark YouDerm Emtrix.
Moberg Derma president and CEO Peter Wolpert said that the agreement is part of their international commercialization of Emtrix.
"As the leading Italian pharmaceutical group, ranked 34th in the world, Menarini is well positioned to make Emtrix a success in Italy," Wolpert added.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.